In the last 12 months, insiders at Scholar Rock Holding Corp ($SRRK) filed 284 transactions with the SEC: 9 open-market purchases totaling $19,988,986 and 111 sales totaling $161,162,250. Net insider sentiment: net selling.
Scholar Rock Holding Corp operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Invus Public Equities, L.P. (Not found) — 6 transactions totaling $82,397,639
- AKKARAJU SRINIVAS (Not found) — 16 transactions totaling $62,200,968
- Myles Edward H (COO & CFO) — 28 transactions totaling $17,710,551
- Qatanani Mo (CHIEF SCIENTIFIC OFFICER) — 57 transactions totaling $16,504,600
- Invus Global Management, LLC (Not found) — 2 transactions totaling $11,576,309
View all SEC Filings for Scholar Rock Holding Corp (SRRK).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 200 | $48.48 | 98,445.0000 | 114,701,154 | 0.20% | 0.00% |
| Feb. 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 7427 | $46.94 | 99,502.0000 | 114,701,154 | 6.95% | 0.01% |
| Feb. 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 857 | $47.86 | 98,645.0000 | 114,701,154 | 0.86% | 0.00% |
| Feb. 17, 2026 | Parlavecchio Caryn | CHRO | S | Common Stock | 9035 | $46.53 | 169,087.0000 | 114,701,154 | 5.07% | 0.01% |
| Feb. 17, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 7989 | $46.53 | 106,929.0000 | 114,701,154 | 6.95% | 0.01% |
| Feb. 17, 2026 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 4157 | $46.53 | 126,012.0000 | 114,701,154 | 3.19% | 0.00% |
| Feb. 17, 2026 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 9580 | $46.53 | 241,545.0000 | 114,701,154 | 3.81% | 0.01% |
| Feb. 9, 2026 | Woods Keith | Chief Operating Officer | A | Common Stock | 47021 | $0.00 | 630,275.0000 | 114,701,154 | 8.06% | 0.04% |
| Feb. 9, 2026 | Vaishnaw Akshay | President of R&D | A | Common Stock | 47021 | $0.00 | 642,788.0000 | 114,701,154 | 7.89% | 0.04% |
| Feb. 9, 2026 | Sinha Vikas | Chief Financial Officer | A | Common Stock | 47021 | $0.00 | 630,266.0000 | 114,701,154 | 8.06% | 0.04% |
| Feb. 9, 2026 | Qatanani Mo | Chief Scientific Officer | A | Common Stock | 29258 | $0.00 | 114,918.0000 | 114,701,154 | 34.16% | 0.03% |
| Feb. 9, 2026 | Parlavecchio Caryn | Chief Human Resources Officer | A | Common Stock | 29258 | $0.00 | 178,122.0000 | 114,701,154 | 19.65% | 0.03% |
| Feb. 9, 2026 | Marantz Jing L. | Chief Medical Officer | A | Common Stock | 34482 | $0.00 | 130,169.0000 | 114,701,154 | 36.04% | 0.03% |
| Feb. 9, 2026 | Ho Junlin | General Counsel | A | Common Stock | 36572 | $0.00 | 251,125.0000 | 114,701,154 | 17.05% | 0.03% |
| Feb. 9, 2026 | Hallal David | Chief Executive Officer | A | Common Stock | 128004 | $0.00 | 1,874,649.0000 | 114,701,154 | 7.33% | 0.11% |
| Dec. 11, 2025 | Invus Global Management, LLC | Not found | X | Common Stock | 1575008 | $7.35 | 10,825,013.0000 | 113,729,850 | 17.03% | 1.38% |
| Dec. 11, 2025 | Invus Global Management, LLC | Not found | X | Warrant (right to buy) | 1575008 | $0.00 | 0.0000 | 113,729,850 | 100.00% | 1.38% |
| Jan. 22, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2119 | $45.87 | 98,439.0000 | 114,701,154 | 2.11% | 0.00% |
| Jan. 22, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 12779 | $46.85 | 85,660.0000 | 114,701,154 | 12.98% | 0.01% |
| Jan. 16, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8406 | $44.48 | 100,558.0000 | 114,701,154 | 7.71% | 0.01% |
| Jan. 16, 2026 | Parlavecchio Caryn | CHRO | S | Common Stock | 6600 | $44.48 | 148,864.0000 | 114,701,154 | 4.25% | 0.01% |
| Jan. 16, 2026 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 5798 | $44.48 | 95,687.0000 | 114,701,154 | 5.71% | 0.01% |
| Jan. 16, 2026 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 8016 | $44.48 | 214,553.0000 | 114,701,154 | 3.60% | 0.01% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 13112 | $45.20 | 108,964.0000 | 114,701,154 | 10.74% | 0.01% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1407 | $0.00 | 0.0000 | 114,701,154 | 100.00% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 2813 | $0.00 | 11,250.0000 | 114,701,154 | 20.00% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 321 | $0.00 | 961.0000 | 114,701,154 | 25.04% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 5893 | $0.00 | 47,143.0000 | 114,701,154 | 11.11% | 0.01% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 2678 | $0.00 | 32,142.0000 | 114,701,154 | 7.69% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 1407 | $18.08 | 110,371.0000 | 114,701,154 | 1.29% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 321 | $7.62 | 110,692.0000 | 114,701,154 | 0.29% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 2813 | $10.00 | 113,505.0000 | 114,701,154 | 2.54% | 0.00% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 5893 | $15.75 | 119,398.0000 | 114,701,154 | 5.19% | 0.01% |
| Jan. 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 2678 | $35.15 | 122,076.0000 | 114,701,154 | 2.24% | 0.00% |
| Jan. 13, 2026 | Sinha Vikas | Chief Financial Officer | S | Common Stock | 16755 | $42.70 | 583,245.0000 | 114,701,154 | 2.79% | 0.01% |
| Jan. 13, 2026 | Woods Keith | Chief Operating Officer | S | Common Stock | 16746 | $42.70 | 583,254.0000 | 114,701,154 | 2.79% | 0.01% |
| Jan. 13, 2026 | Vaishnaw Akshay | President of R&D | S | Common Stock | 20438 | $42.70 | 595,767.0000 | 114,701,154 | 3.32% | 0.02% |
| Jan. 13, 2026 | Hallal David | Chief Executive Officer | S | Common Stock | 57450 | $42.70 | 1,746,645.0000 | 114,701,154 | 3.18% | 0.05% |
| Dec. 16, 2025 | Peng Katie | Not found | S | Common Stock | 726 | $43.88 | 33,188.0000 | 113,729,850 | 2.14% | 0.00% |
| Dec. 16, 2025 | Peng Katie | Not found | S | Common Stock | 280 | $44.63 | 32,908.0000 | 113,729,850 | 0.84% | 0.00% |
| Oct. 7, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 12796 | $39.31 | 6,901,981.0000 | 113,729,850 | 0.19% | 0.01% |
| Dec. 12, 2025 | AKKARAJU SRINIVAS | Not found | X | Warrants to Purchase Common Stock | 1064804 | $0.00 | 0.0000 | 113,729,850 | 100.00% | 0.94% |
| Dec. 12, 2025 | AKKARAJU SRINIVAS | Not found | X | Common Stock | 1064804 | $7.35 | 6,918,784.0000 | 113,729,850 | 18.19% | 0.94% |
| Oct. 7, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 4403 | $40.97 | 6,918,784.0000 | 113,729,850 | 0.06% | 0.00% |
| Oct. 7, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 12400 | $40.18 | 6,914,381.0000 | 113,729,850 | 0.18% | 0.01% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 65625 | $26.05 | 174,589.0000 | 113,729,850 | 60.23% | 0.06% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 136462 | $45.21 | 108,964.0000 | 113,729,850 | 55.60% | 0.12% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 65625 | $0.00 | 4,375.0000 | 113,729,850 | 93.75% | 0.06% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 21093 | $0.00 | 1,407.0000 | 113,729,850 | 93.75% | 0.02% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 5607 | $0.00 | 0.0000 | 113,729,850 | 100.00% | 0.00% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1281 | $0.00 | 1,282.0000 | 113,729,850 | 49.98% | 0.00% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 11250 | $0.00 | 14,063.0000 | 113,729,850 | 44.44% | 0.01% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 23571 | $0.00 | 53,036.0000 | 113,729,850 | 30.77% | 0.02% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 8035 | $0.00 | 34,820.0000 | 113,729,850 | 18.75% | 0.01% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 5607 | $4.86 | 201,289.0000 | 113,729,850 | 2.87% | 0.00% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 1281 | $7.62 | 202,570.0000 | 113,729,850 | 0.64% | 0.00% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 11250 | $10.00 | 213,820.0000 | 113,729,850 | 5.55% | 0.01% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 23571 | $15.75 | 237,391.0000 | 113,729,850 | 11.02% | 0.02% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 8035 | $35.15 | 245,426.0000 | 113,729,850 | 3.38% | 0.01% |
| Dec. 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 21093 | $18.08 | 195,682.0000 | 113,729,850 | 12.08% | 0.02% |
| Oct. 8, 2025 | Hallal David | Chief Executive Officer | G | Common Stock | 205000 | $0.00 | 1,804,095.0000 | 113,729,850 | 10.20% | 0.18% |
| Oct. 3, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 11011 | $35.61 | 5,334,953.0000 | 113,729,850 | 0.21% | 0.01% |
| Oct. 6, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 13748 | $39.52 | 5,824,381.0000 | 113,729,850 | 0.24% | 0.01% |
| Oct. 6, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 80863 | $38.68 | 5,810,633.0000 | 113,729,850 | 1.41% | 0.07% |
| Oct. 6, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 18414 | $37.89 | 5,729,770.0000 | 113,729,850 | 0.32% | 0.02% |
| Oct. 3, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 319700 | $37.42 | 5,711,356.0000 | 113,729,850 | 5.93% | 0.28% |
| Oct. 3, 2025 | AKKARAJU SRINIVAS | Not found | P | Common Stock | 56703 | $36.74 | 5,391,656.0000 | 113,729,850 | 1.06% | 0.05% |
| Sept. 22, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 3353 | $30.67 | 108,964.0000 | 112,703,014 | 2.99% | 0.00% |
| Sept. 16, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 3178 | $33.52 | 112,317.0000 | 112,703,014 | 2.75% | 0.00% |
| Sept. 16, 2025 | Peng Katie | Not found | S | Common Stock | 930 | $32.48 | 33,990.0000 | 112,703,014 | 2.66% | 0.00% |
| Sept. 16, 2025 | Peng Katie | Not found | S | Common Stock | 76 | $33.20 | 33,914.0000 | 112,703,014 | 0.22% | 0.00% |
| Aug. 18, 2025 | Parlavecchio Caryn | CHRO | S | Common Stock | 2178 | $31.17 | 155,464.0000 | 112,703,014 | 1.38% | 0.00% |
| July 16, 2025 | FLIER JEFFREY S. | Not found | S | Common Stock | 11136 | $40.02 | 24,070.0000 | 112,703,014 | 31.63% | 0.01% |
| July 8, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 24066 | $34.44 | 115,495.0000 | 112,703,014 | 17.24% | 0.02% |
| June 23, 2025 | FLIER JEFFREY S. | Not found | S | Common Stock | 11136 | $33.21 | 35,206.0000 | 111,838,272 | 24.03% | 0.01% |
| June 23, 2025 | FLIER JEFFREY S. | Not found | S | Common Stock | 2766 | $32.74 | 35,206.0000 | 111,838,272 | 7.28% | 0.00% |
| June 23, 2025 | FLIER JEFFREY S. | Not found | S | Common Stock | 17550 | $32.16 | 37,972.0000 | 111,838,272 | 31.61% | 0.02% |
| June 23, 2025 | FLIER JEFFREY S. | Not found | M | Common Stock | 20316 | $21.62 | 55,522.0000 | 111,838,272 | 57.71% | 0.02% |
| June 23, 2025 | FLIER JEFFREY S. | Not found | M | Stock Option (Right to Buy) | 20316 | $0.00 | 0.0000 | 111,838,272 | 100.00% | 0.02% |
| June 16, 2025 | Peng Katie | Not found | S | Common Stock | 54 | $32.53 | 34,920.0000 | 111,838,272 | 0.15% | 0.00% |
| June 16, 2025 | Peng Katie | Not found | S | Common Stock | 2977 | $31.96 | 34,974.0000 | 111,838,272 | 7.84% | 0.00% |
| June 16, 2025 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 7442 | $32.00 | 222,569.0000 | 111,838,272 | 3.24% | 0.01% |
| June 16, 2025 | Parlavecchio Caryn | CHRO | S | Common Stock | 6186 | $32.00 | 157,642.0000 | 111,838,272 | 3.78% | 0.01% |
| June 16, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 3668 | $32.00 | 139,561.0000 | 111,838,272 | 2.56% | 0.00% |
| June 9, 2025 | Ho Junlin | GENERAL COUNSEL | A | Common Stock | 8571 | $0.00 | 230,011.0000 | 111,838,272 | 3.87% | 0.01% |
| June 9, 2025 | Ho Junlin | GENERAL COUNSEL | A | Stock Option (Right to Buy) | 11429 | $0.00 | 11,429.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 29, 2025 | Gilman Michael | Not found | S | Common Stock | 2745 | $29.83 | 55,216.0000 | 111,838,272 | 4.74% | 0.00% |
| May 29, 2025 | Gilman Michael | Not found | S | Common Stock | 630 | $29.22 | 57,961.0000 | 111,838,272 | 1.08% | 0.00% |
| May 29, 2025 | Burow Kristina | Not found | S | Common Stock | 4400 | $29.83 | 2,366,782.0000 | 111,838,272 | 0.19% | 0.00% |
| May 29, 2025 | Burow Kristina | Not found | S | Common Stock | 1000 | $29.24 | 2,371,182.0000 | 111,838,272 | 0.04% | 0.00% |
| May 29, 2025 | FLIER JEFFREY S. | Not found | S | Common Stock | 4975 | $29.84 | 46,342.0000 | 111,838,272 | 9.69% | 0.00% |
| May 29, 2025 | FLIER JEFFREY S. | Not found | S | Common Stock | 1100 | $29.23 | 51,317.0000 | 111,838,272 | 2.10% | 0.00% |
| May 29, 2025 | Brudnick Richard | Not found | S | Common Stock | 1400 | $30.00 | 15,057.0000 | 111,838,272 | 8.51% | 0.00% |
| May 29, 2025 | Reed Joshua | Not found | S | Common Stock | 4900 | $29.68 | 16,232.0000 | 111,838,272 | 23.19% | 0.00% |
| May 29, 2025 | Reed Joshua | Not found | S | Common Stock | 500 | $30.04 | 15,732.0000 | 111,838,272 | 3.08% | 0.00% |
| May 29, 2025 | Vaishnaw Akshay | President of R&D | S | Common Stock | 1620 | $30.01 | 616,205.0000 | 111,838,272 | 0.26% | 0.00% |
| May 29, 2025 | Vaishnaw Akshay | President of R&D | S | Common Stock | 5130 | $29.63 | 617,825.0000 | 111,838,272 | 0.82% | 0.00% |
| May 29, 2025 | Brudnick Richard | Not found | S | Common Stock | 4675 | $29.63 | 16,457.0000 | 111,838,272 | 22.12% | 0.00% |
| May 22, 2025 | Peng Katie | Director | A | Common Stock | 7632 | $0.00 | 37,951.0000 | 111,838,272 | 25.17% | 0.01% |
| May 22, 2025 | Brudnick Richard | Director | A | Common Stock | 7632 | $0.00 | 21,132.0000 | 111,838,272 | 56.53% | 0.01% |
| May 22, 2025 | Brudnick Richard | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 22, 2025 | Reed Joshua | Director | A | Common Stock | 7632 | $0.00 | 21,132.0000 | 111,838,272 | 56.53% | 0.01% |
| May 22, 2025 | Reed Joshua | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 22, 2025 | Burow Kristina | Director | A | Common Stock | 7632 | $0.00 | 2,372,182.0000 | 111,838,272 | 0.32% | 0.01% |
| May 22, 2025 | Burow Kristina | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 22, 2025 | AKKARAJU SRINIVAS | Director | A | Common Stock | 7632 | $0.00 | 5,634,028.0000 | 111,838,272 | 0.14% | 0.01% |
| May 22, 2025 | AKKARAJU SRINIVAS | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 22, 2025 | Peng Katie | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 22, 2025 | Gilman Michael | Director | A | Common Stock | 7632 | $0.00 | 58,591.0000 | 111,838,272 | 14.98% | 0.01% |
| May 22, 2025 | Gilman Michael | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 22, 2025 | FLIER JEFFREY S. | Director | A | Common Stock | 7632 | $0.00 | 52,417.0000 | 111,838,272 | 17.04% | 0.01% |
| May 22, 2025 | FLIER JEFFREY S. | Director | A | Stock Option (Right to Buy) | 9206 | $0.00 | 9,206.0000 | 111,838,272 | 9999.99% | 0.01% |
| May 2, 2025 | Woods Keith | Chief Operating Officer | A | Stock Option (Right to Buy) | 110067 | $0.00 | 110,067.0000 | 111,838,272 | 9999.99% | 0.10% |
| May 2, 2025 | Hallal David | Chief Executive Officer | A | Stock Option (Right to Buy) | 275167 | $0.00 | 275,167.0000 | 111,838,272 | 9999.99% | 0.25% |
| May 2, 2025 | Sinha Vikas | Chief Financial Officer | A | Stock Option (Right to Buy) | 110067 | $0.00 | 110,067.0000 | 111,838,272 | 9999.99% | 0.10% |
| May 2, 2025 | Vaishnaw Akshay | President of R&D | A | Stock Option (Right to Buy) | 110067 | $0.00 | 110,067.0000 | 111,838,272 | 9999.99% | 0.10% |
| April 25, 2025 | Sacco Tracey | Chief Commercial Officer | M | Common Stock | 5000 | $10.00 | 76,250.0000 | 111,838,272 | 7.02% | 0.00% |
| April 27, 2025 | Sinha Vikas | Chief Financial Officer | A | Common Stock | 500000 | $0.00 | 600,000.0000 | 111,838,272 | 500.00% | 0.45% |
| April 27, 2025 | Sinha Vikas | Chief Financial Officer | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 111,838,272 | 9999.99% | 0.09% |
| April 27, 2025 | Hallal David | CEO | A | Common Stock | 1250000 | $0.00 | 1,804,095.0000 | 111,838,272 | 225.59% | 1.12% |
| April 27, 2025 | Hallal David | CEO | A | Common Stock | 250000 | $0.00 | 554,095.0000 | 111,838,272 | 82.21% | 0.22% |
| April 27, 2025 | Vaishnaw Akshay | President of R&D | A | Common Stock | 500000 | $0.00 | 622,955.0000 | 111,838,272 | 406.65% | 0.45% |
| April 27, 2025 | Vaishnaw Akshay | President of R&D | A | Common Stock | 100000 | $0.00 | 122,955.0000 | 111,838,272 | 435.63% | 0.09% |
| April 27, 2025 | Woods Keith | Chief Operating Officer | A | Common Stock | 500000 | $0.00 | 600,000.0000 | 111,838,272 | 500.00% | 0.45% |
| April 27, 2025 | Woods Keith | Chief Operating Officer | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 111,838,272 | 9999.99% | 0.09% |
| April 25, 2025 | Sacco Tracey | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 185,000.0000 | 111,838,272 | 2.63% | 0.00% |
| April 25, 2025 | Sacco Tracey | Chief Commercial Officer | S | Common Stock | 84 | $33.49 | 71,750.0000 | 111,838,272 | 0.12% | 0.00% |
| April 25, 2025 | Sacco Tracey | Chief Commercial Officer | S | Common Stock | 4916 | $32.81 | 71,834.0000 | 111,838,272 | 6.41% | 0.00% |
| March 24, 2025 | Moore Erin | Interim PFO and PAO | M | Common Stock | 8564 | $13.52 | 96,173.0000 | 99,838,102 | 9.78% | 0.01% |
| March 24, 2025 | Sacco Tracey | Chief Commercial Officer | M | Common Stock | 5000 | $10.00 | 78,250.0000 | 99,838,102 | 6.83% | 0.01% |
| March 24, 2025 | Sacco Tracey | Chief Commercial Officer | S | Common Stock | 1500 | $33.70 | 76,750.0000 | 99,838,102 | 1.92% | 0.00% |
| March 24, 2025 | Sacco Tracey | Chief Commercial Officer | S | Common Stock | 5000 | $32.89 | 71,750.0000 | 99,838,102 | 6.51% | 0.01% |
| March 24, 2025 | Sacco Tracey | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 190,000.0000 | 99,838,102 | 2.56% | 0.01% |
| March 24, 2025 | Moore Erin | Interim PFO and PAO | M | Common Stock | 5000 | $23.86 | 87,609.0000 | 99,838,102 | 6.05% | 0.01% |
| March 24, 2025 | Moore Erin | Interim PFO and PAO | S | Common Stock | 13564 | $33.12 | 82,609.0000 | 99,838,102 | 14.10% | 0.01% |
| March 24, 2025 | Moore Erin | Interim PFO and PAO | M | Stock Option (Right to Buy) | 5000 | $0.00 | 11,764.0000 | 99,838,102 | 29.83% | 0.01% |
| March 24, 2025 | Moore Erin | Interim PFO and PAO | M | Stock Option (Right to Buy) | 8564 | $0.00 | 40,724.0000 | 99,838,102 | 17.38% | 0.01% |
| March 17, 2025 | Peng Katie | Not found | S | Common Stock | 1006 | $34.42 | 30,319.0000 | 99,838,102 | 3.21% | 0.00% |
| March 10, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 32145 | $0.00 | 143,229.0000 | 99,838,102 | 28.94% | 0.03% |
| March 10, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 42855 | $0.00 | 42,855.0000 | 99,838,102 | 9999.99% | 0.04% |
| March 10, 2025 | Parlavecchio Caryn | CHRO | A | Common Stock | 23570 | $0.00 | 163,828.0000 | 99,838,102 | 16.80% | 0.02% |
| March 10, 2025 | Parlavecchio Caryn | CHRO | A | Stock Option (Right to Buy) | 31430 | $0.00 | 31,430.0000 | 99,838,102 | 9999.99% | 0.03% |
| March 10, 2025 | Marantz Jing L. | CHIEF MEDICAL OFFICER | A | Common Stock | 34285 | $0.00 | 101,485.0000 | 99,838,102 | 51.02% | 0.03% |
| March 10, 2025 | Marantz Jing L. | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 45715 | $0.00 | 45,715.0000 | 99,838,102 | 9999.99% | 0.05% |
| March 10, 2025 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Common Stock | 113570 | $0.00 | 425,561.0000 | 99,838,102 | 36.40% | 0.11% |
| March 10, 2025 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 151430 | $0.00 | 151,430.0000 | 99,838,102 | 9999.99% | 0.15% |
| March 10, 2025 | Ho Junlin | GENERAL COUNSEL | A | Common Stock | 32145 | $0.00 | 221,440.0000 | 99,838,102 | 16.98% | 0.03% |
| March 10, 2025 | Ho Junlin | GENERAL COUNSEL | A | Stock Option (Right to Buy) | 42855 | $0.00 | 42,855.0000 | 99,838,102 | 9999.99% | 0.04% |
| March 10, 2025 | Sacco Tracey | Chief Commercial Officer | A | Common Stock | 27855 | $0.00 | 73,250.0000 | 99,838,102 | 61.36% | 0.03% |
| March 10, 2025 | Sacco Tracey | Chief Commercial Officer | A | Stock Option (Right to Buy) | 37145 | $0.00 | 37,145.0000 | 99,838,102 | 9999.99% | 0.04% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Common Stock | 43122 | $18.08 | 205,552.0000 | 99,838,102 | 26.55% | 0.04% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Common Stock | 24915 | $4.86 | 230,467.0000 | 99,838,102 | 12.12% | 0.02% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Common Stock | 21690 | $13.83 | 162,430.0000 | 99,838,102 | 15.41% | 0.02% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 21690 | $0.00 | 0.0000 | 99,838,102 | 100.00% | 0.02% |
| March 10, 2025 | Myles Edward H | COO & CFO | S | Common Stock | 29395 | $34.87 | 111,345.0000 | 99,838,102 | 20.89% | 0.03% |
| March 10, 2025 | Myles Edward H | COO & CFO | S | Common Stock | 112897 | $35.82 | 140,740.0000 | 99,838,102 | 44.51% | 0.11% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Common Stock | 17857 | $15.75 | 253,637.0000 | 99,838,102 | 7.57% | 0.02% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Common Stock | 5313 | $10.00 | 235,780.0000 | 99,838,102 | 2.31% | 0.01% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 43122 | $0.00 | 14,378.0000 | 99,838,102 | 74.99% | 0.04% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 24915 | $0.00 | 12,462.0000 | 99,838,102 | 66.66% | 0.02% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 17857 | $0.00 | 53,573.0000 | 99,838,102 | 25.00% | 0.02% |
| March 10, 2025 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 5313 | $0.00 | 42,500.0000 | 99,838,102 | 11.11% | 0.01% |
| Feb. 18, 2025 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S | Common Stock | 18372 | $36.83 | 311,991.0000 | 99,838,102 | 5.56% | 0.02% |
| Feb. 18, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 4135 | $36.83 | 131,286.0000 | 99,838,102 | 3.05% | 0.00% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 16818 | $4.86 | 148,104.0000 | 99,838,102 | 12.81% | 0.02% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 2562 | $7.62 | 150,666.0000 | 99,838,102 | 1.73% | 0.00% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 11250 | $10.00 | 161,916.0000 | 99,838,102 | 7.47% | 0.01% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 17678 | $15.75 | 179,594.0000 | 99,838,102 | 10.92% | 0.02% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 39967 | $37.20 | 139,627.0000 | 99,838,102 | 22.25% | 0.04% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8341 | $37.56 | 131,286.0000 | 99,838,102 | 5.97% | 0.01% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 20202 | $37.74 | 111,084.0000 | 99,838,102 | 15.39% | 0.02% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 16818 | $0.00 | 5,607.0000 | 99,838,102 | 75.00% | 0.02% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 2562 | $0.00 | 2,563.0000 | 99,838,102 | 49.99% | 0.00% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 11250 | $0.00 | 25,313.0000 | 99,838,102 | 30.77% | 0.01% |
| Feb. 19, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 17678 | $0.00 | 76,607.0000 | 99,838,102 | 18.75% | 0.02% |
| Feb. 18, 2025 | Parlavecchio Caryn | CHRO | S | Common Stock | 5296 | $36.83 | 140,258.0000 | 99,838,102 | 3.64% | 0.01% |
| Feb. 18, 2025 | Myles Edward H | COO & CFO | S | Common Stock | 7809 | $36.83 | 140,740.0000 | 99,838,102 | 5.26% | 0.01% |
| Feb. 18, 2025 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 5742 | $36.83 | 189,295.0000 | 99,838,102 | 2.94% | 0.01% |
| Jan. 16, 2025 | Myles Edward H | COO & CFO | S | Common Stock | 12539 | $44.20 | 148,549.0000 | 99,838,102 | 7.78% | 0.01% |
| Jan. 16, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 7347 | $44.20 | 135,421.0000 | 99,838,102 | 5.15% | 0.01% |
| Jan. 16, 2025 | Parlavecchio Caryn | CHRO | S | Common Stock | 6434 | $44.20 | 145,554.0000 | 99,838,102 | 4.23% | 0.01% |
| Jan. 16, 2025 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 9039 | $44.20 | 195,037.0000 | 99,838,102 | 4.43% | 0.01% |
| Jan. 16, 2025 | Sacco Tracey | Chief Commercial Officer | S | Common Stock | 3890 | $44.20 | 45,395.0000 | 99,838,102 | 7.89% | 0.00% |
| Jan. 16, 2025 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 5655 | $44.20 | 67,200.0000 | 99,838,102 | 7.76% | 0.01% |
| Jan. 16, 2025 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S | Common Stock | 22308 | $44.20 | 330,363.0000 | 99,838,102 | 6.33% | 0.02% |
| Dec. 10, 2024 | Invus Public Equities, L.P. | Not found | S | Common Stock | 1600000 | $41.65 | 9,250,005.0000 | 97,050,637 | 14.75% | 1.65% |
| Nov. 25, 2024 | Invus Public Equities, L.P. | Not found | S | Common Stock | 149 | $40.98 | 10,850,005.0000 | 97,050,637 | 0.00% | 0.00% |
| Nov. 25, 2024 | Invus Public Equities, L.P. | Not found | S | Common Stock | 126442 | $39.51 | 10,880,837.0000 | 97,050,637 | 1.15% | 0.13% |
| Nov. 25, 2024 | Invus Public Equities, L.P. | Not found | S | Common Stock | 43887 | $38.43 | 11,007,279.0000 | 97,050,637 | 0.40% | 0.05% |
| Nov. 25, 2024 | Invus Public Equities, L.P. | Not found | S | Common Stock | 208272 | $37.63 | 11,051,166.0000 | 97,050,637 | 1.85% | 0.21% |
| Nov. 25, 2024 | Invus Public Equities, L.P. | Not found | S | Common Stock | 30683 | $40.14 | 10,850,154.0000 | 97,050,637 | 0.28% | 0.03% |
| Nov. 22, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 2145 | $0.00 | 136,375.0000 | 97,050,637 | 1.55% | 0.00% |
| Nov. 25, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 200 | $40.72 | 72,855.0000 | 97,050,637 | 0.27% | 0.00% |
| Nov. 25, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 3075 | $39.93 | 73,055.0000 | 97,050,637 | 4.04% | 0.00% |
| Nov. 25, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 2100 | $39.25 | 76,130.0000 | 97,050,637 | 2.68% | 0.00% |
| Nov. 25, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 1000 | $38.04 | 78,230.0000 | 97,050,637 | 1.26% | 0.00% |
| Nov. 25, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Common Stock | 6375 | $8.59 | 79,230.0000 | 97,050,637 | 8.75% | 0.01% |
| Nov. 22, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 2145 | $30.01 | 72,855.0000 | 97,050,637 | 2.86% | 0.00% |
| Nov. 22, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Common Stock | 2145 | $8.59 | 75,000.0000 | 97,050,637 | 2.94% | 0.00% |
| Nov. 25, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 6375 | $0.00 | 130,000.0000 | 97,050,637 | 4.67% | 0.01% |
| Nov. 11, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 2105 | $0.00 | 138,520.0000 | 97,050,637 | 1.50% | 0.00% |
| Nov. 12, 2024 | Gilman Michael | Not found | G | Common Stock | 37459 | $0.00 | 50,959.0000 | 97,050,637 | 42.37% | 0.04% |
| Nov. 12, 2024 | Gilman Michael | Not found | G | Common Stock | 37459 | $0.00 | 50,959.0000 | 97,050,637 | 277.47% | 0.04% |
| Nov. 11, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Common Stock | 2105 | $8.59 | 74,960.0000 | 97,050,637 | 2.89% | 0.00% |
| Nov. 11, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 2105 | $30.00 | 72,855.0000 | 97,050,637 | 2.81% | 0.00% |
| Oct. 8, 2024 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 37187 | $0.00 | 47,813.0000 | 97,050,637 | 43.75% | 0.04% |
| Oct. 8, 2024 | Myles Edward H | COO & CFO | M | Common Stock | 37187 | $10.00 | 198,275.0000 | 97,050,637 | 23.08% | 0.04% |
| Oct. 8, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 37187 | $34.90 | 161,088.0000 | 97,050,637 | 18.76% | 0.04% |
| Oct. 7, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 37206 | $26.83 | 218,150.0000 | 97,050,637 | 14.57% | 0.04% |
| Oct. 7, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 25812 | $27.27 | 192,338.0000 | 97,050,637 | 11.83% | 0.03% |
| Oct. 7, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 31250 | $29.05 | 161,088.0000 | 97,050,637 | 16.25% | 0.03% |
| Oct. 7, 2024 | Myles Edward H | COO & CFO | M | Stock Option (Right to Buy) | 165810 | $0.00 | 0.0000 | 97,050,637 | 100.00% | 0.17% |
| Oct. 7, 2024 | Sacco Tracey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 30000 | $10.00 | 79,285.0000 | 97,050,637 | 60.87% | 0.03% |
| Oct. 7, 2024 | Sacco Tracey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 28036 | $25.58 | 51,249.0000 | 97,050,637 | 35.36% | 0.03% |
| Oct. 7, 2024 | Sacco Tracey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1964 | $26.23 | 49,285.0000 | 97,050,637 | 3.83% | 0.00% |
| Oct. 7, 2024 | Sacco Tracey | CHIEF COMMERCIAL OFFICER | M | Stock Option (Right to Buy) | 30000 | $0.00 | 140,625.0000 | 97,050,637 | 27.12% | 0.03% |
| Oct. 7, 2024 | AKKARAJU SRINIVAS | Not found | S | Common Stock | 510000 | $27.50 | 11,905,005.0000 | 97,050,637 | 4.11% | 0.53% |
| Oct. 7, 2024 | AKKARAJU SRINIVAS | Not found | S | Common Stock | 510000 | $30.00 | 12,060,718.0000 | 97,050,637 | 4.06% | 0.53% |
| Oct. 7, 2024 | AKKARAJU SRINIVAS | Not found | S | Common Stock | 155713 | $32.50 | 11,905,005.0000 | 97,050,637 | 1.29% | 0.16% |
| Oct. 7, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Common Stock | 109375 | $8.59 | 182,230.0000 | 97,050,637 | 150.13% | 0.11% |
| Oct. 7, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 67448 | $25.59 | 114,782.0000 | 97,050,637 | 37.01% | 0.07% |
| Oct. 7, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 2552 | $26.22 | 112,230.0000 | 97,050,637 | 2.22% | 0.00% |
| Oct. 7, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 109375 | $0.00 | 140,625.0000 | 97,050,637 | 43.75% | 0.11% |
| Oct. 7, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | S | Common Stock | 39375 | $30.06 | 72,855.0000 | 97,050,637 | 35.08% | 0.04% |
| Oct. 7, 2024 | Myles Edward H | COO & CFO | M | Common Stock | 206240 | $13.83 | 367,328.0000 | 97,050,637 | 35.96% | 0.21% |
| Oct. 7, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 111972 | $25.61 | 255,356.0000 | 97,050,637 | 30.48% | 0.12% |
| Sept. 16, 2024 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1936 | $8.58 | 142,768.0000 | 96,813,116 | 1.34% | 0.00% |
| Aug. 16, 2024 | Parlavecchio Caryn | CHRO | S | Common Stock | 1451 | $9.33 | 151,988.0000 | 96,813,116 | 0.95% | 0.00% |
| June 27, 2024 | Peng Katie | Not found | A | Stock Option (Right to Buy) | 6000 | $0.00 | 6,000.0000 | 95,892,601 | 9999.99% | 0.01% |
| June 27, 2024 | Hallal David | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | Hallal David | Not found | A | Common Stock | 13500 | $0.00 | 304,095.0000 | 95,892,601 | 4.65% | 0.01% |
| June 27, 2024 | AKKARAJU SRINIVAS | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | AKKARAJU SRINIVAS | Not found | A | Common Stock | 13500 | $0.00 | 6,802,109.0000 | 95,892,601 | 0.20% | 0.01% |
| June 27, 2024 | Brudnick Richard | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | Brudnick Richard | Not found | A | Common Stock | 13500 | $0.00 | 13,500.0000 | 95,892,601 | 9999.99% | 0.01% |
| June 27, 2024 | FLIER JEFFREY S. | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | FLIER JEFFREY S. | Not found | A | Common Stock | 13500 | $0.00 | 44,785.0000 | 95,892,601 | 43.15% | 0.01% |
| June 27, 2024 | Gilman Michael | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | Gilman Michael | Not found | A | Common Stock | 13500 | $0.00 | 50,959.0000 | 95,892,601 | 36.04% | 0.01% |
| June 27, 2024 | Peng Katie | Not found | A | Common Stock | 4500 | $0.00 | 31,325.0000 | 95,892,601 | 16.78% | 0.00% |
| June 27, 2024 | Reed Joshua | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | Reed Joshua | Not found | A | Common Stock | 13500 | $0.00 | 13,500.0000 | 95,892,601 | 9999.99% | 0.01% |
| June 27, 2024 | Vaishnaw Akshay | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | Vaishnaw Akshay | Not found | A | Common Stock | 13500 | $0.00 | 22,955.0000 | 95,892,601 | 142.78% | 0.01% |
| June 27, 2024 | Burow Kristina | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 95,892,601 | 9999.99% | 0.02% |
| June 27, 2024 | Burow Kristina | Not found | A | Common Stock | 13500 | $0.00 | 2,364,550.0000 | 95,892,601 | 0.57% | 0.01% |
| June 17, 2024 | Parlavecchio Caryn | CHRO | S | Common Stock | 4305 | $8.98 | 153,439.0000 | 95,892,601 | 2.73% | 0.00% |
| June 17, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 9458 | $8.98 | 201,518.0000 | 95,892,601 | 4.48% | 0.01% |
| June 17, 2024 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 4695 | $8.98 | 204,076.0000 | 95,892,601 | 2.25% | 0.00% |
| June 17, 2024 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2315 | $8.99 | 144,704.0000 | 95,892,601 | 1.57% | 0.00% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 276 | $0.00 | 38,915.0000 | 95,892,601 | 0.71% | 0.00% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 322 | $0.00 | 40,108.0000 | 95,892,601 | 0.81% | 0.00% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 27606 | $0.00 | 135,113.0000 | 95,892,601 | 16.97% | 0.03% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 13096 | $0.00 | 38,602.0000 | 95,892,601 | 51.34% | 0.01% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 98257 | $0.00 | 38,639.0000 | 95,892,601 | 71.77% | 0.10% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 98257 | $0.00 | 136,896.0000 | 95,892,601 | 254.29% | 0.10% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 472394 | $0.00 | 1,689,592.0000 | 95,892,601 | 21.85% | 0.49% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 37 | $0.00 | 38,639.0000 | 95,892,601 | 0.10% | 0.00% |
| May 9, 2024 | Nashat Amir | Not found | J | Common Stock | 276 | $0.00 | 38,639.0000 | 95,892,601 | 0.71% | 0.00% |
| April 9, 2024 | Peng Katie | Not found | A | Stock Option (Right to Buy) | 35767 | $0.00 | 35,767.0000 | 95,892,601 | 9999.99% | 0.04% |
| April 9, 2024 | Peng Katie | Not found | A | Common Stock | 26825 | $0.00 | 26,825.0000 | 95,892,601 | 9999.99% | 0.03% |
| Feb. 16, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 4744 | $15.74 | 210,976.0000 | 83,347,086 | 2.20% | 0.01% |
| Feb. 16, 2024 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 3489 | $15.74 | 208,771.0000 | 83,347,086 | 1.64% | 0.00% |
| Feb. 16, 2024 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2512 | $15.74 | 147,019.0000 | 83,347,086 | 1.68% | 0.00% |
| Feb. 16, 2024 | Parlavecchio Caryn | CHRO | S | Common Stock | 3751 | $15.74 | 157,744.0000 | 83,347,086 | 2.32% | 0.00% |
| Feb. 16, 2024 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S | Common Stock | 11614 | $15.74 | 352,671.0000 | 83,347,086 | 3.19% | 0.01% |
| Feb. 12, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | A | Common Stock | 72855 | $0.00 | 72,855.0000 | 83,347,086 | 9999.99% | 0.09% |
| Feb. 12, 2024 | Sacco Tracey | CHIEF COMMERCIAL OFFICER | A | Common Stock | 49285 | $0.00 | 49,285.0000 | 83,347,086 | 9999.99% | 0.06% |
| Feb. 12, 2024 | Sacco Tracey | CHIEF COMMERCIAL OFFICER | A | Stock Option (Right to Buy) | 65715 | $0.00 | 65,715.0000 | 83,347,086 | 9999.99% | 0.08% |
| Feb. 12, 2024 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 70715 | $0.00 | 149,531.0000 | 83,347,086 | 89.72% | 0.08% |
| Feb. 12, 2024 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 94285 | $0.00 | 94,285.0000 | 83,347,086 | 9999.99% | 0.11% |
| Feb. 12, 2024 | Parlavecchio Caryn | CHRO | A | Common Stock | 47145 | $0.00 | 161,495.0000 | 83,347,086 | 41.23% | 0.06% |
| Feb. 12, 2024 | Parlavecchio Caryn | CHRO | A | Stock Option (Right to Buy) | 62855 | $0.00 | 62,855.0000 | 83,347,086 | 9999.99% | 0.08% |
| Feb. 12, 2024 | Myles Edward H | COO & CFO | A | Common Stock | 53570 | $0.00 | 215,720.0000 | 83,347,086 | 33.04% | 0.06% |
| Feb. 12, 2024 | Ho Junlin | GENERAL COUNSEL | A | Stock Option (Right to Buy) | 77145 | $0.00 | 77,145.0000 | 83,347,086 | 9999.99% | 0.09% |
| Feb. 12, 2024 | Ho Junlin | GENERAL COUNSEL | A | Common Stock | 57855 | $0.00 | 212,260.0000 | 83,347,086 | 37.47% | 0.07% |
| Feb. 12, 2024 | Myles Edward H | COO & CFO | A | Stock Option (Right to Buy) | 71430 | $0.00 | 71,430.0000 | 83,347,086 | 9999.99% | 0.09% |
| Feb. 12, 2024 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Common Stock | 214285 | $0.00 | 364,285.0000 | 83,347,086 | 142.86% | 0.26% |
| Feb. 12, 2024 | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 285715 | $0.00 | 285,715.0000 | 83,347,086 | 9999.99% | 0.34% |
| Feb. 12, 2024 | Marantz Jing L. | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 97145 | $0.00 | 97,145.0000 | 83,347,086 | 9999.99% | 0.12% |
| Jan. 16, 2024 | Ho Junlin | GENERAL COUNSEL | S | Common Stock | 4186 | $15.93 | 154,405.0000 | 83,347,086 | 2.64% | 0.01% |
| Jan. 16, 2024 | Qatanani Mo | SVP AND HEAD OF RESEARCH | S | Common Stock | 2002 | $15.93 | 78,816.0000 | 83,347,086 | 2.48% | 0.00% |
| Jan. 16, 2024 | Parlavecchio Caryn | CHRO | S | Common Stock | 2849 | $15.93 | 114,350.0000 | 83,347,086 | 2.43% | 0.00% |
| Jan. 16, 2024 | Myles Edward H | COO & CFO | S | Common Stock | 6634 | $15.93 | 162,150.0000 | 83,347,086 | 3.93% | 0.01% |